Richard Kent, Robert Dishman, Kevin Sanborn, William Emhiser | GenomeWeb

Richard Kent has become president and CEO of Serenex, based in Durham, NC. He succeeds Robert Dishman, the company’s founding president, CEO, and chairman.

Prior to joining Serenex, Kent was president and CEO of Ardent Pharmaceuticals. Before that, he held various positions at GlaxoSmith-Kline, including vice president for US medical operations, group medical director, vice president for global medical affairs, and chief medical officer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.